Dermal tissue

The dermal tissue, or dermis, is a thick layer of living tissue located between the epidermis and the subcutaneous fat. It serves as the skin's primary structural support, composed largely of an extracellular matrix (ECM) rich in collagen and elastin fibers produced by resident fibroblasts [1]. Beyond structural integrity, the dermis is highly vascularized and contains various specialized structures, including sweat glands, sebaceous glands, hair follicles, and sensory nerve endings, which collectively facilitate thermoregulation and tactile perception [2][3]. In a clinical context, dermal tissue is not a single molecular target but rather a complex anatomical site for drug action and delivery. It is the primary site of pathology for fibrotic diseases like scleroderma and is critical in the wound healing process [4]. Pharmacological interventions often target specific cellular or molecular components within the dermis, such as using collagenase for Dupuytren's contracture or corticosteroids to reduce dermal inflammation by suppressing fibroblast and immune cell activity. From a drug development perspective, the dermis represents both a barrier and a reservoir for topically and intradermally administered therapeutics [5]. Sources: [1] NIH StatPearls: Skin, Dermis (2023). [2] Cleveland Clinic: Dermis Structure and Function. [3] PubMed: Molecular biology of the dermis (PMC3685324). [4] Journal of Investigative Dermatology: Dermal Fibroblasts in Health and Disease. [5] NIH: Mechanisms of Dermal Drug Delivery.

Other names

DermisCoriumCutis vera

Drugs targeting dermal components typically act by enzymatic degradation of the extracellular matrix (e.g., collagenase), modulation of fibroblast activity and collagen synthesis (e.g., corticosteroids), or physical augmentation of the dermal volume (e.g., dermal fillers) [1][2].